Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT-112 and Gemcitabine in Advanced Solid Tumors
NCT05357196Phase 2Unknown
- Sponsor
- SciClone Pharmaceuticals (Holdings) Limited
- Start
- Apr 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Imifoplatin in biliary tract cancer (BTC), solid tumor, sponsored by SciClone Pharmaceuticals (Holdings) Limited. Status: unknown.
02
Drugs
Imifoplatin
03
Conditions
biliary tract cancer (BTC)solid tumor
Beyond the preview
Go deeper on NCT05357196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357196.